|
1
|
Sun S and Wang Z: Head neck squamous cell
carcinoma c-Met+ cells display cancer stem cell
properties and are responsible for cisplatin-resistance and
metastasis. Int J Cancer. 129:2337–2348. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pearson AT, Jackson TL and Nör JE:
Modeling head and neck cancer stem cell-mediated tumorigenesis.
Cell Mol Life Sci. 73:3279–3289. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Leemans CR, Snijders PJF and Brakenhoff
RH: The molecular landscape of head and neck cancer. Nat Rev
Cancer. 18:269–282. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yu CC, Lo WL, Chen YW, Huang PI, Hsu HS,
Tseng LM, Hung SC, Kao SY, Chang CJ and Chiou SH: Bmi-1 regulates
snail expression and promotes metastasis ability in head and neck
squamous cancer-derived ALDH1 positive cells. J Oncol. 2011:1–16.
2011. View Article : Google Scholar
|
|
5
|
Ringash J: Survivorship and quality of
life in head and neck cancer. J Clin Oncol. 33:3322–3327. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Prince ME and Ailles LE: Cancer stem cells
in head and neck squamous cell cancer. J Clin Oncol. 26:2871–2875.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Plaks V, Kong N and Werb Z: The cancer
stem cell niche: How essential is the niche in regulating stemness
of tumor cells? Cell Stem Cell. 16:225–238. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sayed SI, Dwivedi RC, Katna R, Garg A,
Pathak KA, Nutting CM, Rhys-Evans P, Harrington KJ and Kazi R:
Implications of understanding cancer stem cell (CSC) biology in
head and neck squamous cell cancer. Oral Oncol. 47:237–243. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Abbaszadegan MR, Bagheri V, Razavi MS,
Momtazi AA, Sahebkar A and Gholamin M: Isolation, identification,
and characterization of cancer stem cells (Review). J Cell Physiol.
232:2008–2018. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wolmarans E, Boy SC, Nel S, Mercier AE and
Pepper MS: Cancer stem cells in head and neck carcinomas:
Identification and possible therapeutic implications. Adv Exp Med
Biol. Nov 15–2017.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shaikh MV, Kala M and Nivsarkar M: CD90 a
potential cancer stem cell marker and a therapeutic target. Cancer
Biomark. 16:301–307. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang Q, Shi S, Yen Y, Brown J, Ta JQ and
Le AD: A subpopulation of CD133+ cancer stem-like cells
characterized in human oral squamous cell carcinoma confer
resistance to chemotherapy. Cancer Lett. 289:151–160. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Prince ME, Sivanandan R, Kaczorowski A,
Wolf GT, Kaplan MJ, Dalerba P, Weissman IL, Clarke MF and Ailles
LE: Identification of a subpopulation of cells with cancer stem
cell properties in head and neck squamous cell carcinoma. Proc Natl
Acad Sci USA. 104:973–978. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhou C and Sun B: The prognostic role of
the cancer stem cell marker aldehyde dehydrogenase 1 in head and
neck squamous cell carcinomas: A meta-analysis. Oral Oncol.
50:1144–1148. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pozzi V, Sartini D, Rocchetti R,
Santarelli A, Rubini C, Morganti S, Giuliante R, Calabrese S, Di
Ruscio G, Orlando F, et al: Identification and characterization of
cancer stem cells from head and neck squamous cell carcinoma cell
lines. Cell Physiol Biochem. 36:784–798. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sun W, Bunn P, Jin C, Little P,
Zhabotynsky V, Perou CM, Hayes DN, Chen M and Lin DY: The
association between copy number aberration, DNA methylation and
gene expression in tumor samples. Nucleic Acids Res. 46:3009–3018.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Marzouka NA, Eriksson P, Rovira C,
Liedberg F, Sjödahl G and Höglund M: A validation and extended
description of the Lund taxonomy for urothelial carcinoma using the
TCGA cohort. Sci Rep. 8:37372018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhu J, Sanborn JZ, Benz S, Szeto C, Hsu F,
Kuhn RM, Karolchik D, Archie J, Lenburg ME, Esserman LJ, et al: The
UCSC cancer genomics browser. Nat Methods. 6:239–240. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kokko LL, Hurme S, Maula SM, Alanen K,
Grénman R, Kinnunen I and Ventelä S: Significance of site-specific
prognosis of cancer stem cell marker CD44 in head and neck
squamous-cell carcinoma. Oral Oncol. 47:510–516. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Judd NP, Winkler AE, Murillo-Sauca O,
Brotman JJ, Law JH, Lewis JS Jr, Dunn GP, Bui JD, Sunwoo JB and
Uppaluri R: ERK1/2 regulation of CD44 modulates oral cancer
aggressiveness. Cancer Res. 72:365–374. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Major AG, Pitty LP and Farah CS: Cancer
stem cell markers in head and neck squamous cell carcinoma. Stem
Cells Int. 2013:3194892013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kiang A, Yu MA and Ongkeko WM: Progress
and pitfalls in the identification of cancer stem cell-targeting
therapies in head and neck squamous cell carcinoma. Curr Med Chem.
19:6056–6064. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gilormini M, Wozny AS, Battiston-Montagne
P, Ardail D, Alphonse G and Rodriguez-Lafrasse C: Isolation and
characterization of a head and neck squamous cell carcinoma
subpopulation having stem cell characteristics. J Vis Exp.
2016:e539582016.
|
|
24
|
Zimmerer RM, Ludwig N, Kampmann A,
Bittermann G, Spalthoff S, Jungheim M, Gellrich NC and Tavassol F:
CD24+ tumor-initiating cells from oral squamous cell
carcinoma induce initial angiogenesis in vivo. Microvasc Res.
112:101–108. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Martens-de Kemp SR, Brink A, Stigter-Van
Walsum M, Damen JM, Rustenburg F, Wu T, Van Wieringen WN,
Schuurhuis GJ, Braakhuis BJ, Slijper M, et al: CD98 marks a
subpopulation of head and neck squamous cell carcinoma cells with
stem cell properties. Stem Cell Res. 10:477–488. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Waldron NN, Barsky SH, Dougherty PR and
Vallera DA: A bispecific EpCAM/CD133-targeted toxin is effective
against carcinoma. Target Oncol. 9:239–249. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lim YC, Kang HJ and Moon JH: c-Met pathway
promotes self-renewal and tumorigenecity of head and neck squamous
cell carcinoma stem-like cell. Oral Oncol. 50:633–639. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yan M, Yang X, Wang L, Clark D, Zuo H, Ye
D, Chen W and Zhang P: Plasma membrane proteomics of tumor spheres
identify CD166 as a novel marker for cancer stem-like cells in head
and neck squamous cell carcinoma. Mol Cell Proteomics.
12:3271–3284. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lee SH, Do SI, Lee HJ, Kang HJ, Koo BS and
Lim YC: Notch1 signaling contributes to stemness in head and neck
squamous cell carcinoma. Lab Invest. 96:508–516. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fukusumi T, Ishii H, Konno M, Yasui T,
Nakahara S, Takenaka Y, Yamamoto Y, Nishikawa S, Kano Y, Ogawa H,
et al: CD10 as a novel marker of therapeutic resistance and cancer
stem cells in head and neck squamous cell carcinoma. Br J Cancer.
111:506–514. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yang CC, Zhu LF, Xu XH, Ning TY, Ye JH and
Liu LK: Membrane Type 1 Matrix metalloproteinase induces an
epithelial to mesenchymal transition and cancer stem cell-like
properties in SCC9 cells. BMC Cancer. 13:1712013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chou MY, Hu FW, Yu CH and Yu CC: Sox2
expression involvement in the oncogenicity and radiochemoresistance
of oral cancer stem cells. Oral Oncol. 51:31–39. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chiou SH, Yu CC, Huang CY, Lin SC, Liu CJ,
Tsai TH, Chou SH, Chien CS, Ku HH and Lo JF: Positive correlations
of Oct-4 and Nanog in oral cancer stem-like cells and high-grade
oral squamous cell carcinoma. Clin Cancer Res. 14:4085–4095. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen D, Wu M, Li Y, Chang I, Yuan Q,
Ekimyan-Salvo M, Deng P, Yu B, Yu Y, Dong J, et al: Targeting
BMI1+ cancer stem cells overcomes chemoresistance and
inhibits metastases in squamous cell carcinoma. Cell Stem Cell.
20:621–634.e6. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Oliveira-Costa JP, Oliveira LR, da
Silveira GG, Soave DF, Soares FA and Ribeiro-Silva A: Topoisomerase
expression in oral squamous cell carcinoma: Relationship with
cancer stem cells profiles and lymph node metastasis. J Oral Pathol
Med. 41:762–768. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li Z, Wang Y, Zhu Y, Yuan C, Wang D, Zhang
W, Qi B, Qiu J, Song X, Ye J, et al: The Hippo transducer TAZ
promotes epithelial to mesenchymal transition and cancer stem cell
maintenance in oral cancer. Mol Oncol. 9:1091–1105. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lee CR, Lee SH, Rigas NK, Kim RH, Kang MK,
Park NH and Shin KH: Elevated expression of JMJD6 is associated
with oral carcinogenesis and maintains cancer stemness properties.
Carcinogenesis. 37:119–128. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Shen B, Dong P, Li D and Gao S: Expression
and function of ABCG2 in head and neck squamous cell carcinoma and
cell lines. Exp Ther Med. 2:1151–1157. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lee DG, Lee JH, Choi BK, Kim MJ, Kim SM,
Kim KS, Chang K, Park SH, Bae YS and Kwon BS:
H+-myo-inositol transporter SLC2A13 as a potential
marker for cancer stem cells in an oral squamous cell carcinoma.
Curr Cancer Drug Targets. 11:966–975. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wu MJ, Jan CI, Tsay YG, Yu YH, Huang CY,
Lin SC, Liu CJ, Chen YS, Lo JF and Yu CC: Elimination of head and
neck cancer initiating cells through targeting glucose regulated
protein78 signaling. Mol Cancer. 9:2832010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Da Cruz Paula A and Lopes C: Implications
of different cancer stem cell phenotypes in breast cancer.
Anticancer Res. 37:2173–2183. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Eun K, Ham SW and Kim H: Cancer stem cell
heterogeneity: Origin and new perspectives on CSC targeting. BMB
Rep. 50:117–125. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Han J, Fujisawa T, Husain SR and Puri RK:
Identification and characterization of cancer stem cells in human
head and neck squamous cell carcinoma. BMC Cancer. 14:1732014.
View Article : Google Scholar : PubMed/NCBI
|
